AQR Capital Management LLC Invests $14.83 Million in Grail, Inc. (NASDAQ:GRAL)

AQR Capital Management LLC purchased a new stake in Grail, Inc. (NASDAQ:GRAL) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 830,723 shares of the company’s stock, valued at approximately $14,828,000. AQR Capital Management LLC owned approximately 2.47% of Grail as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of GRAL. FNY Investment Advisers LLC bought a new position in Grail in the 4th quarter valued at about $26,000. State of Tennessee Department of Treasury bought a new position in Grail in the fourth quarter valued at approximately $28,000. Lindbrook Capital LLC bought a new position in Grail in the fourth quarter valued at approximately $28,000. Sterling Capital Management LLC acquired a new position in Grail during the fourth quarter valued at approximately $29,000. Finally, Wellington Shields Capital Management LLC bought a new stake in Grail during the fourth quarter worth $33,000.

Analyst Ratings Changes

A number of equities analysts have recently commented on the company. Canaccord Genuity Group initiated coverage on Grail in a report on Monday, April 21st. They set a “buy” rating and a $32.00 price target for the company. Morgan Stanley boosted their target price on Grail from $16.00 to $20.00 and gave the stock an “equal weight” rating in a research note on Tuesday, March 18th.

Grail Price Performance

Shares of GRAL stock opened at $34.26 on Tuesday. The business’s 50-day moving average price is $29.89 and its 200-day moving average price is $25.29. Grail, Inc. has a 12 month low of $12.33 and a 12 month high of $63.99.

Grail (NASDAQ:GRAL) last issued its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, topping analysts’ consensus estimates of ($4.41) by $2.55. The business had revenue of $38.25 million for the quarter, compared to analyst estimates of $35.33 million. Analysts predict that Grail, Inc. will post -15.15 earnings per share for the current year.

Insider Buying and Selling at Grail

In other Grail news, CFO Aaron Freidin sold 41,150 shares of the firm’s stock in a transaction that occurred on Friday, May 2nd. The shares were sold at an average price of $33.93, for a total transaction of $1,396,219.50. Following the completion of the transaction, the chief financial officer now owns 294,020 shares in the company, valued at approximately $9,976,098.60. This trade represents a 12.28 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Robert P. Ragusa sold 7,625 shares of the business’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $31.21, for a total transaction of $237,976.25. Following the completion of the transaction, the chief executive officer now owns 828,662 shares in the company, valued at $25,862,541.02. This trade represents a 0.91 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 146,735 shares of company stock worth $4,947,263.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.